- Home
- JVA vs ATOS Comparison
JVA vs ATOS Comparison
Compare JVA & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JVA | ATOS |
|---|---|---|
| Founded | 1971 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2M | 24.1M |
| IPO Year | 1997 | 2010 |
Fundamental Metrics
Financial Performance| Metric | JVA | ATOS |
|---|---|---|
| Price | $4.11 | $2.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | ★ 62.5K | 40.7K |
| Earning Date | 06-12-2026 | 05-13-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $90,655,294.00 | $1,758.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.18 | ★ N/A |
| Revenue Growth | ★ 17.54 | N/A |
| 52 Week Low | $2.93 | $0.53 |
| 52 Week High | $5.26 | $7.56 |
Technical Indicators
Market Signals| Indicator | JVA | ATOS |
|---|---|---|
| Relative Strength Index (RSI) | 70.91 | 41.05 |
| Support Level | $3.95 | $2.05 |
| Resistance Level | $4.16 | $2.60 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 83.40 | 0.00 |
Price Performance
Historical ComparisonAbout JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.